Singular Genomics | DEF 14A: Definitive information statements
Singular Genomics | DEFA14A: Others
Singular Genomics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Singular Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Singular Genomics | 8-K: Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
Singular Genomics | 8-K: Current report
Singular Genomics | 8-K: Current report
Singular Genomics | 8-K: Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
Singular Genomics | 8-K: Current report
Singular Genomics | 8-K: Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial Results
Singular Genomics | 8-K: Current report
Singular Genomics | 8-K: Current report
Singular Genomics | 8-K: Current report
Singular Genomics | 8-K: Singular Genomics Reports Recent Highlights and First Quarter 2023 Financial Results
Singular Genomics | DEFA14A: Others
Singular Genomics | DEF 14A: Definitive proxy statements
Singular Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Singular Genomics | 8-K: Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results
Singular Genomics | 8-K: Current report
Singular Genomics | 8-K: Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results
No Data